Dietary D-glucarate effects on the biomarkers of inflammation during early post-initiation stages of benzo[a]pyrene-induced lung tumorigenesis in A/J mice

Oncology Letters

Volumn 2, Issue 1, 2011, Pages 145-154

  Zoltaszek, Robert ^a   Kowalczyk, Piotr ^a   Kowalczyk, Magdalena C ^a   Hanausek, Margaret ^a,b   Kilianska, Zofia M ^c   Slaga, Thomas J ^a,b   Walaszek, Zbigniew ^a,b  

^a UNIVERSITY OF TEXAS HEALTH SCIENCE CENTER AT SAN ANTONIO   (United States)

^b University of Texas Health Science Center at San Antonio   (United States)

^c UNIVERSITY OF LODZ   (Poland)

Author keywords

Apoptosis; Cytokines; Inflammation; Lung cancer; Tumorigenesis

Indexed keywords

BENZO[A]PYRENE; CASPASE 9; GAMMA INTERFERON; INTERLEUKIN 10; INTERLEUKIN 12P70; INTERLEUKIN 6; SACCHARIC ACID; TUMOR NECROSIS FACTOR ALPHA;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; APOPTOSIS; ARTICLE; BLOOD LEVEL; CARCINOGENESIS; CELL PROLIFERATION; CHEMICALLY INDUCED DISORDER; CONTROLLED STUDY; DIET; FEMALE; HOMEOSTASIS; LUNG PARENCHYMA; LUNG TUMOR; MOLECULAR WEIGHT; MOUSE; NONHUMAN;

EID: 78751549459     PISSN: 17921074     EISSN: 17921082     Source Type: Journal    
DOI: 10.3892/ol.2010.221     Document Type: Article

References (68)

1. Ferlay J, Autire P, Boniol M, Heanue M, Colombet M and BoyleP: Estimates of the cancer incidence and mortality in Europe in 2006. Ann Oncol 18: 581-592, 2007.
2. United States Cancer Statistics: Top Ten Cancer, 2006.
3. Landi MT, Consonni D, Rotunno M, et al: Environment and Genetics in Lung cancer Etiology (EAGLE) study: an integrative population-based case-control study of lung cancer. BMC Public Health 8: 203-213, 2008.
4. Miura K, Bowman ED, Simon R, et al: Laser capture microdissection and microarray expression analysis of lung adenocarcinoma reveals tobacco smoking- and prognosis-related molecular profiles. Cancer Res 62: 3244-3250, 2002.
5. Devesa SS, Bray F, Vizcaino AP and Parkin DM: International lung cancer trends by histologic type: male:female differences diminishing and adeno-carcinoma rates rising. Int J Cancer 117: 294-299, 2005.
6. Mountain CF: Revisions in the international system for staging lung cancer. Chest 111: 1710-1717, 1997.
7. Ramaswamy S, Ross KN, Lander ES and Golub TR: A molecular signature of metastasis in primary solid tumors. Nat Genet 33: 49-54, 2003.
8. Garber ME, Troyanskaya OG, Schluens K, et al: Diversity of gene expression in adenocarcinoma of the lung. Proc Natl Acad Sci USA 98: 13784-13789, 2001.
9. Bhattacharjee A, Richards WG, Staunton J, et al: Classification of human lung carcinomas by mRNAexpression profiling reveals distinct adeno-carcinoma subclasses. Proc Natl Acad Sci USA 98: 13790-13795, 2001.
10. Beer DG, Kardia SL, Huang CC, et al: Gene-expression profiles predict survival of patients with lung adenocarcinoma. Nat Med8: 816-824, 2002.
11. Endoh H, Tomida S, Yatabe Y, et al: Prognostic model of pulmonary adenocarcinoma by expression profiling of eight genes as determined by quantitative real-time reverse transcriptase polymerase chain reaction. J Clin Oncol 22: 811-819, 2004.
12. Xi L, Lyons-Weiler J, Coello MC, et al: Prediction of lymph node metastasis by analysis of gene expression profiles in primary lung adenocarcinomas. Clin Cancer Res 11: 4128-4135, 2005.
13. Meyerson M and Carbone D: Genomic and proteomic profiling of lung cancers: lung cancer classification in the age of targeted therapy. J Clin Oncol 23: 3219-3226, 2005.
14. He P, Varticovski L, Bowman ED, et al: Identification of carboxypeptidase E and gamma-glutamyl hydrolase as biomarkers for pulmonary neuro-endocrine tumors by cDNAmicroarray. Hum Pathol 35: 1169-1209, 2004.
15. Yanaihara N, Caplen N, Bowman E, et al: Unique microRNA molecular profiles in lung cancer diagnosis and prognosis. Cancer Cell 9: 189-198, 2006.
16. Potti A, Mukherjee S, Petersen R, et al: A genomic strategy to refine prognosis in early-stage non-small-cell lung cancer. New England J Med 355: 570-580, 2006.
17. Reddy SP: The antioxidant response element and oxidative stress modifiers in airway diseases. Curr Mol Med 8: 376-383, 2008.
18. Walser T, Cui X, Yanagawa J, Lee JM, Heinrich E, Lee G, Sharma S and Dubinett SM: Smoking and lung cancer: the role of inflammation. Proc Am Thorac Soc 5: 811-815, 2008.
19. Giri SN and Hollinger MA: Effect of cadmium on lung lysosomal enzymes in vitro. Arch Toxicol 69: 341-345, 1995.
20. Shimoi K, Saka N, Nozawa R, et al: Deglucuronidation of a flavonoid, luteolin monglucuronide, during inflammation. Drug Metab Disp 29: 1521-1524, 2001.
21. Marshall T, Shult P and Busse WW: Release of lysosomal enzyme β-glucuronidase from isolated human eosinophils. J Allergy Clin Immunol 82: 550-555, 1988.
22. Cobben NA, Drent M, De Vries J, Wouters EF, van Dieijen-VisserMP and Henderson RF: Serum β-glucuronidase activity in a population of ex-coalminers. Clin Biochem 32: 659-664, 1999.
23. DiMatteo M, Antonini JM, van Dyke K and Reasor MJ: Characteristics of the acute phase pulmonary response to silica in rats. J Toxicol Environ Health 47: 93-108, 1996.
24. DiMatteo M and Reasor MJ: Modulation of silica-induced pulmonary toxicity by dexamethasone-containing liposomes. Toxicol Appl Pharmacol 142: 411-421, 1997.
25. Hirano S, Shimada T, Osugi J, Kodama N and Suzuki KT: Pulmonary clearance and inflammatory potence intratracheally instilled or acutely inhaled nickel sulfate in rats. Arch Toxicol68: 548-554, 1994.
26. Matulionis D and Traurig HH: In situ response of lung macrophages and hydrolase activities to cigarette smoke. Lab Invest 37: 314-326, 1977.
27. Pappas P, Sotiropoulou M, Karamanakos P, et al: Acute-phase response to benzo[a]pyrene and induction of rat ALDH3A1. Chem Bil Interac 144: 55-62, 2003.
28. Kong LY, Luster MI, Dixon D, O'Grady J and Rosenthal GJ: Inhibition of lung immunity after tracheal instillation of benzo[a]pyrene. Am J Resp Cit Care Med 150: 1123-1129, 1994.
29. Levy G and Conchi J: β-Glucuronidase and the hydrolysis of glucuronides. In: Glucuronic Acid: Free and Combined. Academic Press, New York, pp 301-364, 1966.
30. Marsh CA: Metabolism of D-glucarolactone in mammalian systems. Identification of D-glucaric acid as a normal constituent of urine. Biochem J 86: 77-86, 1963.
31. Matsui M, Fukuo A, Watanabe Y, Wanibe T and Okada M: Studies on the glucaric acid pathway in the metabolism of D-glucuronic acid in mammals. IV. Fluorometric method for the determination of D-glucaric acid in serum. Chem Phar Bull 20: 845-848, 1972.
32. Blumenthal HJ, Lucuta VL and Blumenthal DC: Specific enzymic assay for D-glucarate in human serum. Anal Biochem185: 286-293, 1990.
33. Colombi A, Maroni M, Antonini C, Fait A, Zocchetti C and Foa V: Influence of sex, age and smoking habits on the urinary excretion of D-glucaric acid. Clin Chim Acta 128: 349-358, 1983.
34. Mocarelli P, Brambilla P, Colombo L, et al: A new method for D-glucaric acid excretion measurement that is suitable for automated instruments. Clin Chem 34: 2238-2290, 1988.
35. Batt HM and Siest G: Laboratory tests as indirect indications of the activity of drug metabolizing enzymes: use of glucaric acid and gamma-glutamyl-transpeptidase. Dev Clin Biochem 2: 178-192, 1980.
36. Yokoyama M, Matsuoka S and Wakui A: Activation of tegafur and urinary excretion of D-glucaric acid in tumor-bearing hosts: In: Recent Adv Chemother, Proc Int Congr Chemother 14th, Univ Tokyo Press, Tokyo, pp 113-115, 1985.
37. Dohrmann RE: β-Glucuronidase. Springer-Verlag, Berlin, 1969.
38. Masaki H: Metabolic pathway of dermal D-glucaric acid synthesis from D-glucuronolactone. D-Glucaric acid and D-glucuronolactone dehydrogenase in human skin. β-Gucuronidase feedback mechanism. Nippon Hifuka Gakkai Zashi 82: 151-158; Chem Abstr 78: 2709b, 27062u, 1972.
39. Dutton GJ: Glucuronidation of Drugs and Other Compounds. CRC Press, Boca Raton, FL, 1980.
40. Clark AG, Fischer FJ, Milburn P, Smith RL and Williams RL: The role of gut flora in the enterohepatic circulation of stilboestrol in the rat. Biochem J 112: P17-P18, 1988.
41. Walaszek Z: Potential use of D-glucaric acid derivatives in cancer prevention. Cancer Lett 54: 1-8, 1990.
42. Walaszek Z: Chemopreventive properties of D-glucaric acid derivatives. Cancer Bull 45: 453-457, 1993.
43. Yoshimi N, Walaszek Z, Mori H, Hanausek M, Szemraj J and Slaga TJ: Inhibition of azoxymethane-induced rat colon carcinogenesis by potassium hydrogen D-glucarate. Int J Oncol 16: 43-48, 2000.
44. Walaszek Z, Szemraj J, Hanausek M, Adams AK and ShermanU: D-Glucaric acid content of various fruits and vegetables and cholesterol lowering effects of dietary D-glucarate in the rat. Nutr Res 16: 673-682, 1996.
45. Zoltaszek R, Hanausek M, Kiliańska ZM and Walaszek Z: The biological role of D-glucaric acid and its derivatives: potential use in medicine. Adv Hyg Exptl Med 62: 451-462, 2008.
46. Kishimoto T: Interleukin-6: from basic science to medicine - 40years in immunology. Annu Rev Immunol 23: 1-21, 2005.
47. Wajant H, Pfizenmaier K and Scheurich P: Tumor necrosis factor signaling. Cell Death Differ 10: 45-65, 2003.
48. Coussens LM and Werb Z: Inflammatory cells and cancer: think different! J Exp Med 193: F23-F26, 2001.
49. Coussens LM and Werb Z: Inflammation and cancer. Nature420: 860-867, 2001.
50. Zoltaszek R, Hanausek M, Slaga TJ and Walaszek Z: Proapoptotic effects of D-glucarate on chemically induced lung tumorigenesis in A/J mice. Proc Am Assoc Cancer Res 48: 795, 2007.
51. Zoltaszek R, Grzelak M, Hanausek M, Kilianska Z, SlagaTJ and Walaszek Z: Effects of dietary D-glucarate on biomarkers of inflammation during early post-initiation stages of benzo[a]pyrene (B[a]P)-induced lung tumorigenesis in A/J mice. Proc Am Assoc Cancer Res 49: 532, 2008.
52. Rodriguez-Manzaneque JC, Lane TF, Ortega MA, Hynes RO, Lawler J and Iruela-Arispe M: Thrombospondin-1 suppresses spontaneous tumor growth and inhibits activation of matrix metalloproteinase-9 and mobilization of vascular endothelial growth factor. PNAS USA 98: 12485-12490, 2001.
53. De Marzo AM, Marchi VL, Epstein JI and Nelson WG: Proliferative inflammatory atrophy of the prostate: implications for prostatic carcinogenesis. Am J Pathol 155: 1985-1992, 1999.
54. Kuper H and Adami HO and Trichopoulos D: Infections as a major preventable cause of human cancer. J Intern Med 248: 171-173, 2000.
55. Baron JA and Sandler RS: Nonsteroidal anti-inflammatory drugs and cancer prevention. Annu Rev Med 51: 511-523, 2000.
56. Williams CS, Mann M and DuBois RN: The role of cyclooxygenases in inflammation, cancer, and development. Oncogene 18: 7908-7916, 1999.
57. Di Carlo E, Forni G, Lollini P, Colombo MP, Modesti A and Musiani P: The intriguing role of polymorphonuclear neutrophils in anti-tumor reactions. Blood 97: 339-345, 2001.
58. Wahl LM and Kleinman HK: Tumor-associated macrophages as targets for cancer therapy. J Natl Cancer Inst 90: 1583-1584, 1998.
59. Coussens LM, Raymond WW, Bergers G, et al: Inflammatory mast cells up-regulate angiogenesis during squamous epithelial carcinogenesis. Genes Dev 13: 1382-1397, 1999.
60. Rothenberg ME: Eosinophilia. N Eng J Med 338: 1592-1600, 1998.
61. Gouon-Evans V, Rothenberg ME and Pollard JW: Postnatal mammary gland development requires macrophages and eosinophils. Development 127: 2269-2282, 2000.
62. Lin EY, Nguyen AV, Russel RG and Pollard JW: Colony-stimulating factor 1 promotes progression of mammary tumors to malignancy. J Exp Med 193: 727-740, 2001.
63. Ono M, Torisu H, Fukushi J, Nishie A and Kuwano M: Biological implications of macrophage infiltration in human angiogenesis. Cancer Chemother Pharmacol 43: S69-S71, 1999.
64. Torisu H, Ono M, Kiryu H, Furue M, Ohmoto Y, Nakayama J, Nishioka Y, Sone S and Kuwano M: Macrophage infiltration correlates with tumor stage and angiogenesis in human malignant melanoma: possible involvement of TNFalpha and IL-1alpha. Int J Cancer 85: 182-188, 2000.
65. Coussens LM, Tinkel CL, Hanahan D. and Werb Z: MMP-9 supplied by bone marrow-derived cells contributes to skin carcinogenesis. Cell 103: 481-490, 2000.
66. Walaszek Z, Hanausek-Walaszek M and Webb TE: Dietary glucarate-mediated reduction of sensitivity of murine strains to chemical carcinogenesis. Cancer Lett 33: 25-32, 1986.
67. Gysin R, Azzi A and Visarius T: Gamma-tocopherol inhibits human cancer cell cycle progression and cell proliferation by down-regulation of cyclins. FASEB J 16: 1952-1954, 2002.
68. Boivin D, Blanchette M, Barrette S, Moghrabi A, and BéliveauR: Inhibition of cancer cell proliferation and suppression of TNF-induced activation of NFkappaB by edible berry juice. Anticancer Res 27: 937-948, 2007.